ALGBE Global Bioenergies SA

Global Bioenergies announces the appointment of Martin Stephan as Chief Business Officer

Global Bioenergies announces the appointment of Martin Stephan as Chief Business Officer

PRESS RELEASE

Global Bioenergies announces the appointment of

Martin Stephan as Chief Business Officer

Evry, 19 October 2023 – 7:45 a.m. : Martin Stephan joins Global Bioenergies as Chief Business Officer.

Martin Stephan has spent his entire career in the chemical industry, in France, Germany, Italy and Switzerland. As Deputy Chief Executive Officer of CARBIOS from 2017 to 2022, he notably contributed to the strong growth of this major listed player in the green chemistry market.

He previously held strategic positions as Head of International Sales in global groups, particularly in The Chemours Company and Du Pont de Nemours, the world leader in innovative specialty products for industry. Martin Stephan is a graduate of HEC.

Martin Stephan comments: “ I am delighted to be joining the Global Bioenergies teams, whose technology is extremely well positioned to meet the challenge of energy and environmental transition.

This appointment is intended to support the Company's scale-up, which includes the commissioning of a new plant with a capacity of 10,000 tonnes per year of isobutene and derivatives in 2027, to serve the cosmetics and sustainable aviation fuel markets.

Marc Delcourt, co-founder and CEO of Global Bioenergies, adds: “Martin Stephan’s experience in promoting innovation will enable us to establish and strengthen strong commercial partnerships in our various markets.”

About GLOBAL BIOENERGIES

Global Bioenergies substitutes products of fossil origin with products of natural origin. In their quest for naturalness without compromising on performance, the cosmetics players are the Company's first customers. By 2027, the Company will be operating its innovative process in a large-scale plant. By 2030, the Company plans to become a leader in the huge emerging market for sustainable aviation fuels, in order to fight against global warming. Global Bioenergies is listed on Euronext Growth in Paris (FR0011052257 - ALGBE). L'Oréal is its largest shareholder, with a 13.5% stake.

Contacts

GLOBAL BIOENERGIES

+33 (0)1 64 98 20 50





 



Follow our news



 



Receive information about Global Bioenergies directly by subscribing to our news feed on



 



 



Follow us on LinkedIn:





 
  



 



NewCap – Investor relations



Louis-Victor Delouvrier

Quentin Massé





+33 (0)1 44 71 94 94



 



 



NewCap – Media relations



 



Nicolas Merigeau



+33 (0)1 44 71 94 98

Attachment



EN
19/10/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Global Bioenergies SA

 PRESS RELEASE

GLOBAL BIOENERGIES: judicial liquidation and delisting of shares

GLOBAL BIOENERGIES: judicial liquidation and delisting of shares Evry, 01 December 2025 – 5:30pm: At the hearing to examine the bids held on November 24, the Evry Commercial Court examined the two final takeover bids submitted. In a ruling handed down today, neither bid was accepted by the Court, the first bid was rejected due to the lack of employee retention and the second on the grounds that it did not meet the conditions for a satisfactory takeover. The Evry Commercial Court therefore decided to convert the receivership procedure into judicial liquidation and appointed Maître Alain-Fra...

 PRESS RELEASE

GLOBAL BIOENERGIES : liquidation judiciaire et radiation des actions à...

GLOBAL BIOENERGIES : liquidation judiciaire et radiation des actions à venir Evry, le 1er décembre 2025 : Lors de l’audience d’examen des offres qui s’est tenue le 24 novembre dernier, le Tribunal de Commerce d’Evry a examiné les deux offres de reprise finales déposées. Aux termes d’un jugement rendu ce jour, aucune des deux offres n’a été retenue par le Tribunal, la première offre en raison de l’absence de reprise de salariés et la seconde au motif qu’elle ne remplissait pas les conditions permettant une reprise satisfaisante. Le Tribunal de Commerce d’Evry a ainsi décidé de convertir le ...

 PRESS RELEASE

Global Bioenergies: postponement of the takeover offers review hearing...

Global Bioenergies: postponement of the takeover offers review hearing to 24 November PRESS RELEASE Global Bioenergies: postponement of the takeover offers review hearing to 24 November Evry, 04 November 2025 – 05:45 p.m: The hearing which was held yesterday at the Commercial Court of Evry concluded with the decision to postpone until 24 November 2025 the review of the offers to take over Global Bioenergies’ activities. The new deadline for submitting the offers has been set up on 12 November 2025. As a reminder, the company had initiated a pre-pack sale process on 03 June 2025 and t...

 PRESS RELEASE

Global Bioenergies : renvoi de l’audience d’examen des offres au 24 no...

Global Bioenergies : renvoi de l’audience d’examen des offres au 24 novembre COMMUNIQUE DE PRESSE Global Bioenergies : renvoi de l’audience d’examen des offres au 24 novembre Evry, le 04 novembre 2025 - 17h45 : L’audience qui s’est tenue hier au Tribunal de Commerce d’Evry s’est conclue sur la décision de renvoyer l’examen des offres de reprise des activités de la société Global Bioenergies au lundi 24 novembre 2025. Une nouvelle date limite de dépôt des offres a été fixée au 12 novembre 2025 à midi. Pour rappel, la Société s’était inscrite dans un processus de pré-pack cession le 3...

 PRESS RELEASE

Global Bioenergies: opening of a receivership procedure

Global Bioenergies: opening of a receivership procedure PRESS RELEASE Global Bioenergies: opening of a receivership procedure Evry, 29 September 2025 – 05:45 p.m: The Evry Commercial Court today opened a receivership procedure towards Global Bioenergies and appointed SCP Abitbol & Rousselet, represented by Maître Joanna Rousselet (previously the company's conciliator), as administrator. This procedure is a continuation of the pre-pack sale process initiated on 03 June 20251. The objective of this procedure is to evaluate and implement solutions that would make it possible to continue the ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch